Structure-activity study at positions 3 and 4 of human neuropeptide S

被引:14
作者
Camarda, Valeria [3 ,4 ,5 ]
Trapella, Claudio [1 ,2 ]
Calo, Girolamo [3 ,4 ,5 ]
Guerrini, Remo [1 ,2 ]
Rizzi, Anna [3 ,4 ,5 ]
Ruzza, Chiara [3 ,4 ,5 ]
Fiorini, Stella [1 ,2 ]
Marzola, Erika [1 ,2 ]
Reinscheid, Rainer K. [6 ]
Regoli, Domenico [3 ,4 ,5 ]
Salvadori, Severo [1 ,2 ]
机构
[1] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy
[2] Univ Ferrara, Ctr Biotechnol, I-44100 Ferrara, Italy
[3] Univ Ferrara, Dept Expt & Clin Med, Pharmacol Sect, I-44100 Ferrara, Italy
[4] Univ Ferrara, Dept Expt & Clin Med, Ctr Neurosci, I-44100 Ferrara, Italy
[5] Natl Inst Neurosci, Turin, Italy
[6] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA
关键词
neuropeptide S; bioassay; structure-activity study; peptide synthesis;
D O I
10.1016/j.bmc.2008.08.073
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Neuropeptide S (NPS) has been identified as the endogenous ligand of a previously orphan receptor now named NPSR. Previous studies demonstrated that the N-terminal sequence Phe(2)-Arg(3)-Asn(4) of the peptide is crucial for biological activity. Here, we report on a focused structure-activity study of Arg(3) and Asn(4) that have been replaced with a series of coded and non-coded amino acids. Thirty-eight human NPS analogues were synthesized and pharmacologically tested for intracellular calcium mobilization using HEK293 cells stably expressing the mouse NPSR. The results of this study demonstrated the following NPS position 3 structure-activity features: (i) the guanidine moiety and its basic character are not crucial requirements, (ii) an aliphatic amino acid with a linear three carbon atom long side chain is sufficient to bind and fully activate NPSR, (iii) the receptor pocket allocating the position 3 side chain can accommodate slightly larger side chains at least to a certain degree [hArg, Arg(NO(2)) or Arg(Me)(2) but not Arg(Tos)]. Position 4 seems to be more sensitive to amino acids replacement compared to position 3; in fact, all the amino acid replacements investigated produced either an important decrease of biological activity or generated inactive derivatives suggesting a pivotal role of the Asn4 side chain for NPS bioactivity. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8841 / 8845
页数:5
相关论文
共 16 条
[1]
Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats [J].
Beck, B ;
Fernette, B ;
Stricker-Krongrad, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 332 (03) :859-865
[2]
Structure-function relationships in the neuropeptide S receptor - Molecular consequences of the asthma-associated mutation N107I [J].
Bernier, Virginie ;
Stocco, Rino ;
Bogusky, Michael J. ;
Joyce, Joseph G. ;
Parachoniak, Christine ;
Grenier, Karl ;
Arget, Michael ;
Mathieu, Marie-Claude ;
O'Neill, Gary P. ;
Slipetz, Deborah ;
Crackower, Michael A. ;
Tan, Christopher M. ;
Therien, Alex G. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (34) :24704-24712
[3]
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 [J].
Camarda, Valeria ;
Trapella, Claudio ;
Calo, Girolamo ;
Guerrini, Remo ;
Rizzi, Anna ;
Ruzza, Chiara ;
Fiorini, Stella ;
Marzola, Erika ;
Reinscheid, Rainer K. ;
Regoli, Domenico ;
Salvadori, Severo .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (03) :655-658
[4]
9-FLUORENYLMETHOXYCARBONYL AMINO-PROTECTING GROUP [J].
CARPINO, LA ;
HAN, GY .
JOURNAL OF ORGANIC CHEMISTRY, 1972, 37 (22) :3404-&
[5]
Anorexigenic effects of central neuropeptide S involve the hypothalamus in chicks (Gallus gallus) [J].
Cline, Mark A. ;
Godlove, David C. ;
Nandar, Wint ;
Bowden, Christie N. ;
Prall, Brian C. .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 2007, 148 (03) :657-663
[6]
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders [J].
Leonard, Sarah K. ;
Dwyer, Jason M. ;
Rizzo, Stacey J. Sukoff ;
Platt, Brian ;
Logue, Sheree F. ;
Neal, Sarah J. ;
Malberg, Jessica E. ;
Beyer, Chad E. ;
Schechter, Lee E. ;
Rosenzweig-Lipson, Sharon ;
Ring, Robert H. .
PSYCHOPHARMACOLOGY, 2008, 197 (04) :601-611
[7]
Direct incorporation of unprotected ketone groups into peptides during solid-phase synthesis: Application to the one-step modification of peptides with two different biophysical probes for FRET [J].
Marcaurelle, LA ;
Bertozzi, CR .
TETRAHEDRON LETTERS, 1998, 39 (40) :7279-7282
[8]
Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor [J].
Okamura, Naoe ;
Habay, Stephen A. ;
Zeng, Joanne ;
Chamberlin, A. Richard ;
Reinscheid, Rainer K. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 325 (03) :893-901
[9]
Pharmacological characterization of human and murine neuropeptide S receptor variants [J].
Reinscheid, RK ;
Xu, YL ;
Okamura, N ;
Zeng, J ;
Chung, SJ ;
Pai, RM ;
Wang, ZW ;
Civelli, O .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03) :1338-1345
[10]
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice [J].
Rizzi, A. ;
Vergura, R. ;
Marzola, G. ;
Ruzza, C. ;
Guerrini, R. ;
Salvadori, S. ;
Regoli, D. ;
Calo, G. .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (02) :471-479